BioAtla sets 2025 bonus targets, elects directors at annual meeting

BioAtla, Inc.

2025 Bonus Plan approved: CEO target 60% of base, CFO 40%, CMO 40%; payout 50%-125%.
Corporate goals: clinical milestones 25%, financing 50%, financial/people 20%, brand awareness 5%.
Annual meeting elected directors Gray, Moran, Steinman; ratified Ernst & Young as auditor (30.2M for).
Say-on-pay non-binding vote passed with 8.96M for vs 4.49M against; 52% of shares voted.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.